Characterization of ABC transporters in human skin

Abstract Background: Most identified drug transporters belong to the ATP-binding cassette (ABC) and solute carrier (SLC) families. Recent research indicates that these transporters play an important role in the absorption, distribution and excretion of drugs, and are involved in clinically relevant drug-drug interactions for systemic drugs. However, very little is known about the role of drug transporters in human skin, especially in the disposition of topically applied drugs, and their involvement in drug-drug interactions. The aim of this work was to characterize the ABC transporters in human skin. Methods: Expressions of ABCB1 multidrug resistance protein 1 (MDR1) also known as P-gp, ABCC1 and ABCC2 multidrug resistance-associated protein 1 and 2 (MRP1 and MRP2), and ABCG2 brest cancer resistance protein (BCRP) in human skin tissues were analyzed by quantitative real-time polymerase chain reaction (RT-PCR). The modulations of ABCB1 and ABCC1 expressions were analyzed after ex vivo treatment of human skin with rifampicin and dexamethasone. The localization of the major transporter MRP1 in human skin was analyzed by immunohistochemistry. Finally, functional analysis of MRP1 in human skin was performed using different specific substrates and inhibitors. Results: The expressions of ABCB1, ABCC1, ABCC2, and ABCG2 were all detected in human skin, of which the expression of ABCC1 was considered the most important. The comparison of human skin with human hepatocytes and kidneys shows that the expression of ABCC1 increased 15-fold in skin than in hepatocytes. Immunohistochemistry revealed marked expressions of MRP1 within the hair follicle, sweat gland and muscle, as well as moderate expression in the basal epidermis. Functional analysis demonstrated that the skin absorptions of rhodamine 123, [3H]-vinblastine, and [3H]-LTC4 were markedly decreased in the presence of MRP1 inhibitors (verapamil and MK571), thus supporting the role of MRP1 in the uptake of compounds from the epidermal compartment as well as their secretion into the bloodstream and sweat ducts. Conclusions: The present findings are the first to demonstrate the involvement of MRP1 in drug uptake in human skin.

[1]  P. Elias.  Skin barrier function , 2008, Current allergy and asthma reports.

[2]  Clive P. Page,et al.  Trends in Pharmacological Sciences , 1989 .

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  K. Madison,et al.  Barrier function of the skin: "la raison d'être" of the epidermis. , 2003, The Journal of investigative dermatology.

[5]  F. Lammert,et al.  Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.

[6]  D. Jäger,et al.  The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes , 2000, Cell.

[7]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[8]  H. Merk,et al.  Active transport of contact allergens and steroid hormones in epidermal keratinocytes is mediated by multidrug resistance related proteins. , 2010, The Journal of investigative dermatology.

[9]  T. D. de Gruijl,et al.  Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation1 , 2006, The Journal of Immunology.

[10]  R. Potts.  Skin Barrier: Principles of Percutaneous Absorption , 1997 .

[11]  P. Cuq,et al.  Combined effects of GSTP1 and MRP1 in melanoma drug resistance , 2005, British Journal of Cancer.

[12]  Adrian C. Williams,et al.  Transdermal and Topical Drug Delivery : From Theory to Clinical Practice , 2003 .

[13]  R. Steinman,et al.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Yan,et al.  Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23. , 2010, Biochemical pharmacology.

[15]  B. Weill,et al.  Expression and induction by dexamethasone of ABC transporters and nuclear receptors in a human T-lymphocyte cell line , 2012, Journal of chemotherapy.

[16]  J. Watson,et al.  Neonatal murine epidermal cells express a functional multidrug-resistant pump. , 2000, The Journal of investigative dermatology.

[17]  Gillian Smith,et al.  Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. , 2003, The Journal of investigative dermatology.

[18]  F. Guissard,et al.  Biochemical Pharmacology , 1960, Nature.

[19]  Sean Kim,et al.  CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[20]  Marilyn E Morris,et al.  MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells , 2009, Molecular Pharmacology.

[21]  Experimental Therapeutics.  Pharmacology research & perspectives , 2013 .

[22]  A. Bosserhoff,et al.  Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells , 2007, Melanoma research.

[23]  A. D. Rodrigues,et al.  Enzyme- and transporter-based drug-drug Interaction , 2010 .

[24]  I. Cascorbi,et al.  Down-Regulation of ATP-Binding Cassette C2 Protein Expression in HepG2 Cells after Rifampicin Treatment Is Mediated by MicroRNA-379 , 2011, Molecular Pharmacology.

[25]  A. Kim,et al.  P‐Glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components , 2011, Experimental dermatology.

[26]  Hyunsuk Shim,et al.  Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. , 2010, Biochemical pharmacology.

[27]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[28]  P. Sexton,et al.  Molecular Pharmacology , 1965, Nature.

[29]  D. Keppler,et al.  Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain , 2004, Neuroscience.

[30]  Thomas Ried,et al.  Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 , 2009, Molecular Cancer Therapeutics.

[31]  I TOEROE,et al.  [ON THE LYMPH NODES]. , 1964, Verhandlungen der Anatomischen Gesellschaft.

[32]  Christopher M Waters,et al.  Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. , 2008, American journal of physiology. Cell physiology.

[33]  Gillian Smith,et al.  Regulation of cutaneous drug‐metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo , 2006, The British journal of dermatology.

[34]  T. Imai,et al.  Multidrug Resistance—Associated Protein 1 Functions as an Efflux Pump of Xenobiotics in the Skin , 2005, Pharmaceutical Research.

[35]  G. Siest,et al.  Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. , 1989, Biochemical pharmacology.

[36]  G. Randolph.  Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. , 2001, Seminars in immunology.

[37]  J. Herskowitz,et al.  Proceedings of the National Academy of Sciences, USA , 1996, Current Biology.

[38]  Yukio Kato,et al.  P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[39]  X. Ruan,et al.  Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane X receptor. , 2012, Investigative ophthalmology & visual science.

[40]  Olga Kovalchuk,et al.  Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin , 2008, Molecular Cancer Therapeutics.

[41]  M. Caraglia,et al.  The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? , 2008, The Journal of investigative dermatology.

[42]  H. Swanson.  Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. , 2004, Chemico-biological interactions.

[43]  N. Kanof,et al.  The Journal of Investigative Dermatology , 1967 .

[44]  P. Heinrich,et al.  Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. , 2005, The Journal of investigative dermatology.